Roogold Announces Appointment of Daniel Cohen to Board of Directors

July 14, 2022

TORONTO, ON / ACCESSWIRE / July 14, 2022 / (CSE:ROO)(OTC PINK:JNCCF)(Frankfurt:5VHA) -RooGold Inc. (“RooGold” or the “Company“) is pleased to announce the appointment of Daniel Cohen to the Company’s board of directors, effective July 14, 2022.

Daniel Cohen, CFA is presently Chairman and CEO of PharmaDrug Inc (CSE:PHRX), a Canadian

listed biotech company. He is also the Chairman and co-founder of Caprock Mining Corp. (CSE:CAPR), a Canadian listed gold exploration company. Before taking on his role at PharmaDrug, Daniel spent nearly 20 years working in the Canadian capital markets. His most recent role was as Principal and Head of Institutional Sales at Beacon Securities. Prior to his role at Beacon Securities, Mr. Cohen was a partner and Director of Institutional Sales at Wellington West Capital Markets. He began his career in equity research at RBC Capital Markets and HSBC Securities.

“We’re excited to welcome Daniel to our team at this time,” said Carlos Espinosa, President and CEO of RooGold. “We look forward to his diverse skills, perspectives and expertise contributing to the ongoing success of RooGold.”